PureTech Health to Present at the Leerink Partners 6th Annual Global Healthcare Conference
07 February 2017 - 6:00PM
Business Wire
PureTech Health plc (LSE: PRTC), a cross-disciplinary
biopharmaceutical company, today announced that Daphne Zohar,
PureTech Health’s Chief Executive Officer, will present at the
Leerink Partners 6th Annual Global Healthcare Conference on
Thursday, February 16, 2017 at 2:00pm EST.
A webcast of the presentation will be available at
http://puretechhealth.com/investors.php under the Reports and
Presentations tab.
About PureTech HealthPureTech Health (PureTech
Health plc, PRTC.L) is a cross-disciplinary biopharmaceutical
company creating 21st century medicines that modulate the adaptive
human systems. Our therapies target the immune, nervous, and
gastro-intestinal systems by addressing the underlying
pathophysiology of disease from a systems perspective rather than
through a single receptor or pathway. We have multiple human
proof-of-concept studies and pivotal or registration studies
expected to read out in the next two years. PureTech Health’s rich
and growing research and development pipeline has been developed in
collaboration with some of the world’s leading scientific experts
who, along with PureTech's experienced team and board, analyze more
than 650 scientific discoveries per year to identify and advance
only the opportunities we believe hold the most promise for
patients. This team and process place PureTech Health on the
cutting edge of ground-breaking science and technological
innovation and leads the Company between and beyond existing
disciplines. For more information, visit www.puretechhealth.com or
connect with us on Twitter.
Forward Looking StatementThis press release contains
statements that are or may be forward-looking statements, including
statements that relate to the company's future prospects,
developments and strategies. The forward-looking statements are
based on current expectations and are subject to known and unknown
risks and uncertainties that could cause actual results,
performance and achievements to differ materially from current
expectations, including, but not limited to, those risks and
uncertainties described in the risk factors included in the
regulatory filings for PureTech Health plc. These forward-looking
statements are based on assumptions regarding the present and
future business strategies of the company and the environment in
which it will operate in the future. Each forward-looking statement
speaks only as at the date of this press release. Except as
required by law and regulatory requirements, neither the company
nor any other party intends to update or revise these
forward-looking statements, whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170206006228/en/
PureTech HealthMedia:Allison Mead, +1
617-651-3156amead@puretechhealth.comorInvestors:Graham Morrell, +1
617-986-1659gm@puretechhealth.com
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Apr 2024 to May 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From May 2023 to May 2024